Statistics for iTeos Therapeutics, (id:6551 ITOS)

Valuation metrics

Market cap

335.64M

Enterprise value

-230,104,240.00

Trailing P/E (ttm)

40.83

Forward P/E

-1.57

PEG ratio

-1.57

Price/Sales (ttm)

9.59

Price/Book (mrq)

0.51

Enterprise Value/Revenue

-6.57

Enterprise Value/EBITDA

1.65

Overview

Shares outstanding

36.52M

Float

23.93M

Shares short

3.82M

% Held by insiders

0.01%

% Held by institutions

1.10%

Average volume (10 days)

538.17K

Average volume (90 days)

Price summary

52-Week low

7.54

52-Week high

18.75

52-Week change

-10.82%

Beta

1.39

50-Day moving average

10.84

200-Day moving average

13.13

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-37.92%

Operational effectiveness

Return on assets

-12.05%

Return on equity

-16.80%

Income statement

Revenue (ttm)

0.95

Revenue per share (ttm)

0.95

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-139,264,992.00

Net income to common (ttm)

-108,135,000.00

Diluted EPS (ttm)

-2.96

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

571.26M

Total cash per share (mrq)

15.64

Total debt (mrq)

5.52M

Total Debt/Equity (mrq)

0.83

Current ratio (mrq)

1.81K%

Book value per share (mrq)

18.18

Cash flow

Cash flow statement

-113,982,000.00

Levered free cash flow (LFCF)

-96,239,248.00